Once-Weekly Semaglutide in Adults with Overweight or Obesity
In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body we...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 3,574
- Institution
- Novo Nordisk (Denmark)
External Links
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.